Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Surgical/GSI

This article was originally published in The Gray Sheet

Executive Summary

Firms ink two three-year distribution agreements, one giving USSC non-exclusive, worldwide rights to market General Surgical Innovation's Spacemaker surgical balloon dissectors for use in hernia repair and incontinence procedures. In return, GSI acquires non-exclusive, worldwide rights to market USSC's ProTack mesh fixation device as part of a complete hernia repair kit. In February, GSI's exclusive rights agreement with Ethicon for the Spacemaker was downgraded to nonexclusive, opening the door for USSC

You may also be interested in...

Tyco Makes Space For General Surgical Innovations Alongside USSC

Tyco International's $100 mil. stock-swap acquisition of minimally invasive balloon dissection device maker General Surgical Innovations is expected to close within the next 90 days, GSI estimates.

Aducanumab Review: Looking For Precedents – Long Ago And Far Afield

The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts